Company SyneuRx International (Taiwan) Corp.

Equities

6575

TW0006575004

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Taipei Exchange Other stock markets 04:30:00 06/01/2023 am IST			5-day change	1st Jan Change
17.2 ^TWD	-.--%		-.--%	-.--%

29/04	SyneuRx International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	SyneuRx International Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

SyneuRx International Taiwan Corp is a Taiwan-based company mainly engaged in the development of new drugs. The Company is mainly engaged in the research and development of new drugs for treatment of coronavirus disease (COVID-19), schizophrenia, dementia and depression. Its clinical trials include SNB01 COVID-19 Antiviral, SND13 Adult Schizophrenia Study, SND12 Refractory Schizophrenia and SND11 Adolescent Schizophrenia.

TWD in Million	2022	Weight	2023	Weight	Delta
New Drugs 100.0 %	0	nan %	1	100.0 %	-

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	0	nan %	1	100.0 %	-

Managers	Title	Age	Since
Kuo Chuan Tsai CEO	Chief Executive Officer	-	02/13/02
I Chen Yan DFI	Director of Finance/CFO	-	11/16/11

Members of the board	Title	Age	Since
Mao Chung Chang BRD	Director/Board Member	-	01/20/01
Kuo Chuan Tsai CEO	Chief Executive Officer	-	02/13/02
Cheng Wen Wu BRD	Director/Board Member	-	26/17/26
Chen Wu Chang BRD	Director/Board Member	-	27/16/27
En Kuang Lu BRD	Director/Board Member	-	26/17/26
Pao Tien Lin BRD	Director/Board Member	-	01/20/01
Yang Chan Chang BRD	Director/Board Member	-	01/20/01
Chih Han Chiang BRD	Director/Board Member	-	28/18/28
Chiao Ju Chuang BRD	Director/Board Member	-	03/19/03
Chao Ching Hsu BRD	Director/Board Member	-	28/18/28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	151,089,072	121,089,072 ( 80.14 %)	0	80.14 %

SyneuRx International (Taiwan) Corp.

20F-10 99 Xintai 5th Road Section 1

221 75, New Taipei

http://www.syneurx.com

address SyneuRx International (Taiwan) Corp.(6575)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
SYNEURX INTERNATIONAL (TAIWAN) CORP.	-.--%	7.15Cr
VERTEX PHARMACEUTICALS INCORPORATED	+16.45%	12TCr
REGENERON PHARMACEUTICALS, INC.	+21.96%	12TCr
ARGENX SE	+23.73%	2.7TCr
BIONTECH SE	-20.05%	2.04TCr
BEIGENE, LTD.	-16.28%	1.59TCr
GENMAB A/S	-16.52%	1.64TCr
WUXI APPTEC CO., LTD.	-44.35%	1.56TCr
SAREPTA THERAPEUTICS, INC.	+63.91%	1.49TCr
NEUROCRINE BIOSCIENCES, INC.	+2.52%	1.36TCr

Bio Therapeutic Drugs